Literature DB >> 24059610

Neuroimaging in seizure patients associated with nonketotic hyperglycemia.

C C-C Chen1, J-W Chai, C-H Wu, W-S Chen, H-C Hung, S-K Lee.   

Abstract

Nonketotic hyperglycemia (NKH) is a clinical syndrome consisting of hyperglycemia, hyperosmolality and intracellular dehydration but not ketoacidosis. This prospective study evaluated the clinical and magnetic resonance imaging abnormalities in six patients with NKH complicated with simple or complex partial seizures. Subcortical T2 hypointensity rather than hyperintensity together with contrast enhancement was a characteristic feature of seizures associated with NKH. Restricted diffusion on DWI and decreased NAA and/or Choline on MRS studies were also noted.

Entities:  

Year:  2011        PMID: 24059610     DOI: 10.1177/197140091102400208

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  5 in total

1.  Magnetic resonance imaging findings in patients with non-ketotic hyperglycaemia and focal seizures.

Authors:  Sara Rosa Maria De Martino; Francesco Toni; Luca Spinardi; Luigi Cirillo
Journal:  Neuroradiol J       Date:  2020-06-15

2.  Occipital seizures and persistent homonymous hemianopia with T2 hypointensity on MRI in nonketotic hyperglycemia.

Authors:  Zebun Nissa; Shaista A Siddiqi; Sharifa A M Abdool
Journal:  Epilepsy Behav Case Rep       Date:  2016-05-10

3.  Hyperglycemia-induced seizures - Understanding the clinico- radiological association.

Authors:  Shivaprakash B Hiremath; Amol A Gautam; Prince J George; Agnes Thomas; Reji Thomas; Geena Benjamin
Journal:  Indian J Radiol Imaging       Date:  2019-12-31

4.  Hyperglycemic hemianopia: A case report.

Authors:  Xiao-Hui Xiang; Jia-Jia Fang; Mi Yang; Guo-Hua Zhao
Journal:  World J Clin Cases       Date:  2021-03-06       Impact factor: 1.337

5.  Epileptic seizures during Non-Ketotic Hyperglycemia (NKH) in French Guiana: A retrospective study.

Authors:  Dimitri Baltyde; Bertrand De Toffol; Mathieu Nacher; Nadia Sabbah
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.